165 related articles for article (PubMed ID: 28772256)
1. Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.
Le Rouzic MA; Fouquet C; Leblanc T; Touati M; Fouyssac F; Vermylen C; Jäkel N; Guichard JF; Maloum K; Toutain F; Lutz P; Perel Y; Manceau H; Kannengiesser C; Vannier JP
Blood Cells Mol Dis; 2017 Jul; 66():11-18. PubMed ID: 28772256
[TBL] [Abstract][Full Text] [Related]
2. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.
Bergmann AK; Campagna DR; McLoughlin EM; Agarwal S; Fleming MD; Bottomley SS; Neufeld EJ
Pediatr Blood Cancer; 2010 Feb; 54(2):273-8. PubMed ID: 19731322
[TBL] [Abstract][Full Text] [Related]
3. Three kinships with ALAS2 P520L (c. 1559 C --> T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload.
Lee PL; Barton JC; Rao SV; Acton RT; Adler BK; Beutler E
Blood Cells Mol Dis; 2006; 36(2):292-7. PubMed ID: 16446107
[TBL] [Abstract][Full Text] [Related]
4. Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia.
Kannengiesser C; Sanchez M; Sweeney M; Hetet G; Kerr B; Moran E; Fuster Soler JL; Maloum K; Matthes T; Oudot C; Lascaux A; Pondarré C; Sevilla Navarro J; Vidyatilake S; Beaumont C; Grandchamp B; May A
Haematologica; 2011 Jun; 96(6):808-13. PubMed ID: 21393332
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S
Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018
[TBL] [Abstract][Full Text] [Related]
6. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Pediatr Int; 2013 Dec; 55(6):675-9. PubMed ID: 24003969
[TBL] [Abstract][Full Text] [Related]
8. Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia.
Fernández-Murray JP; Prykhozhij SV; Dufay JN; Steele SL; Gaston D; Nasrallah GK; Coombs AJ; Liwski RS; Fernandez CV; Berman JN; McMaster CR
PLoS Genet; 2016 Jan; 12(1):e1005783. PubMed ID: 26821380
[TBL] [Abstract][Full Text] [Related]
9. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
[TBL] [Abstract][Full Text] [Related]
11. [Congenital sideroblastic anemia-a new family with identification of K156E mutation of ALAS2 gene and literature review].
Cui R; Xu Z; Qin T; Zhang Y; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):142-6. PubMed ID: 24606657
[TBL] [Abstract][Full Text] [Related]
12. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.
Guernsey DL; Jiang H; Campagna DR; Evans SC; Ferguson M; Kellogg MD; Lachance M; Matsuoka M; Nightingale M; Rideout A; Saint-Amant L; Schmidt PJ; Orr A; Bottomley SS; Fleming MD; Ludman M; Dyack S; Fernandez CV; Samuels ME
Nat Genet; 2009 Jun; 41(6):651-3. PubMed ID: 19412178
[TBL] [Abstract][Full Text] [Related]
13. Onset of X-linked sideroblastic anemia in the fourth decade.
Cortesão E; Vidan J; Pereira J; Gonçalves P; Ribeiro ML; Tamagnini G
Haematologica; 2004 Oct; 89(10):1261-3. PubMed ID: 15477213
[TBL] [Abstract][Full Text] [Related]
14. Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports.
Shao Y; He L; Ding S; Fu R
Curr Res Transl Med; 2024 Mar; 72(1):103438. PubMed ID: 38244303
[TBL] [Abstract][Full Text] [Related]
15. Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: phenotype and genotype features of five unrelated patients.
Lee PL; Reid TJ; Bottomley SS; Barton JC
Am J Hematol; 2011 Sep; 86(9):787-9. PubMed ID: 21800356
[No Abstract] [Full Text] [Related]
16. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.
Ducamp S; Kannengiesser C; Touati M; Garçon L; Guerci-Bresler A; Guichard JF; Vermylen C; Dochir J; Poirel HA; Fouyssac F; Mansuy L; Leroux G; Tertian G; Girot R; Heimpel H; Matthes T; Talbi N; Deybach JC; Beaumont C; Puy H; Grandchamp B
Hum Mutat; 2011 Jun; 32(6):590-7. PubMed ID: 21309041
[TBL] [Abstract][Full Text] [Related]
17. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
[TBL] [Abstract][Full Text] [Related]
18. Disparate phenotypic expression of ALAS2 R452H (nt 1407 G --> A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma.
Barton JC; Lee PL
Blood Cells Mol Dis; 2006; 36(3):342-6. PubMed ID: 16540354
[TBL] [Abstract][Full Text] [Related]
19. Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia.
LeBlanc MA; Bettle A; Berman JN; Price VE; Pambrun C; Yu Z; Tiller M; McMaster CR; Fernandez CV
Pediatr Blood Cancer; 2016 Jul; 63(7):1307-9. PubMed ID: 27038157
[TBL] [Abstract][Full Text] [Related]
20. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
